Obalon Therapeutics, Inc. Gains 139.71%
Tue, Apr 14, 2020 at 05:30 PM
Obalon Therapeutics, Inc. (OBLN:NASDAQ) rocketted at $1.63, a gain of 139.7%. The stock appeared on our News Catalysts scanner on Wed 25 Mar 20 at 06:33 PM in the 'MISCELLANEOUS' category. From Mon 30 Mar 20, the stock recorded 33.33% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Obalon Therapeutics, Inc. (OBLN:NASDAQ)
Obalon Therapeutics Inc is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 139.71%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 61.9%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 61.74%
- NeuroMetrix, Inc. (NURO:NASDAQ), 58.73%
- MEI Pharma, Inc. (MEIP:NASDAQ), 49.7%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 47.06%
- MicroVision, Inc. (MVIS:NASDAQ), 44.68%
- Forestar Group Inc. (FOR:NYSE), 42.17%
- Immutep Limited (IMMP:NASDAQ), 40.77%
- RigNet, Inc. (RNET:NASDAQ), 38.79%